美股期權個股詳情
BMBL241129P6000
- 0.22
- 0.000.00%
延時15分鐘行情收盤價 11/26 16:00 (美東)
0.00最高價0.00最低價
0.22今開0.22昨收0張成交量23張未平倉合約數6.00行權價0.00成交額447.01%引伸波幅33.18%溢價2024/11/29到期日0.00内在价值100合約乘數2天距到期日0.22時間價值100合約規模美式期權類型-0.1191Delta0.0626Gamma39.32槓桿倍數-0.1258Theta-0.0001Rho-4.68有效槓桿0.0014Vega
Bumble股票討論
登錄發表評論
Morning Movers
Gapping up
$施貴寶 (BMY.US)$ Shares jumped 3.8% after the FDA approved Cobenfy as a new treatment for schizophrenia in adults, marking the first novel treatment for the mental disorder in several decades.
$永利度假村 (WYNN.US)$ Shares climbed 1.7% following an upgrade to overweight from equal weight by Morgan Stanley, which highlighted the company's strong fundamentals compared to its competitors...
Gapping up
$施貴寶 (BMY.US)$ Shares jumped 3.8% after the FDA approved Cobenfy as a new treatment for schizophrenia in adults, marking the first novel treatment for the mental disorder in several decades.
$永利度假村 (WYNN.US)$ Shares climbed 1.7% following an upgrade to overweight from equal weight by Morgan Stanley, which highlighted the company's strong fundamentals compared to its competitors...
長圖 28
1
1
Good morning, traders. Happy Thursday, the market is trying to climb up after falling back. The Nasdaq and tech stocks were still in correction territory from their heights in the lush days of July. My name is Kevin Travers, here are moovin' stonks.
Eli Lilly $禮來 (LLY.US)$ posted a Q2 earnings beat, boosted by demand for the company's Mounjaro diabetes treatment and weight-loss drug Zepbound. The stock climbed 8%, and ...
Eli Lilly $禮來 (LLY.US)$ posted a Q2 earnings beat, boosted by demand for the company's Mounjaro diabetes treatment and weight-loss drug Zepbound. The stock climbed 8%, and ...
22
3
![[微笑]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "微笑"){kind=small}
1
Morning Movers
Gapping up
$禮來 (LLY.US)$ 's stock increased by 11.5% after the pharmaceutical company boosted its annual profit forecast, with sales of its weight-loss drug Zepbound surpassing the $1 billion mark in a single quarter for the first time.
$蘋果 (AAPL.US)$ 's stock edged up by 0.1% following a report from CNBC that the tech giant may introduce a charge of up to $20 for advanced artificial intelligence f...
Gapping up
$禮來 (LLY.US)$ 's stock increased by 11.5% after the pharmaceutical company boosted its annual profit forecast, with sales of its weight-loss drug Zepbound surpassing the $1 billion mark in a single quarter for the first time.
$蘋果 (AAPL.US)$ 's stock edged up by 0.1% following a report from CNBC that the tech giant may introduce a charge of up to $20 for advanced artificial intelligence f...
28
暫無評論
104476495 : h